| Brooke Kristine Nunemaker, OTR/L | |
|
15301 Grove Cir N, Maple Grove, MN 55369-4475 | |
| (952) 993-5900 | |
| Not Available |
| Full Name | Brooke Kristine Nunemaker |
|---|---|
| Gender | Female |
| Speciality | Occupational Therapist |
| Location | 15301 Grove Cir N, Maple Grove, Minnesota |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1225509466 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 225X00000X | Occupational Therapist | 105851 (Minnesota) | Primary |
| Provider Name | Park Nicollet Clinic |
|---|---|
| Provider Type | Part B Supplier - Clinic/group Practice |
| Provider Identifiers | NPI Number: 1780621904 PECOS PAC ID: 7911819438 Enrollment ID: O20031104000046 |
News Archive
Kansas Health Institute News Service examines accountable care organizations (ACOs): "In an effort to combat the lack of coordination that is widely recognized as a major shortcoming of the current health system, the new federal health reform law includes provisions intended to encourage wider use of Accountable Care Organizations or ACOs."
The U.S. Food and Drug Administration has approved Eli Lilly's Cymbalta, a balanced and potent serotonin and norepinephrine reuptake inhibitor. Cymbalta is the first and only FDA-approved treatment for pain caused by diabetic peripheral neuropathy.
Protalix Biotherapeutics, Inc. (NYSE-Amex: PLX), announced the completion of its pivotal Phase III trial for prGCD, the Company's proprietary plant-cell expressed recombinant form of glucocerebrosidase (GCD) for the treatment of Gaucher disease. The trial enrolled a total of 31 patients across Europe, North America, South America, Israel and South Africa. No serious adverse events were reported in this trial.
A new opinion piece in The BMJ published in March 2020 discusses whether healthcare professionals should wear beards because of the risk that they could harbor the novel coronavirus.
Sundia MediTech Company, a leading pharmaceutical R&D outsourcing service company in China, is proud to announce that the company received the Red Herring Asia Top 100 Enterprises 2009 award, an award given to the top 100 private technology companies in the Asia Pacific region.
› Verified 1 days ago
| Provider Name | Tria Orthopaedic Center Llc |
|---|---|
| Provider Type | Part B Supplier - Clinic/group Practice |
| Provider Identifiers | NPI Number: 1518273085 PECOS PAC ID: 3173570561 Enrollment ID: O20110310000999 |
News Archive
Kansas Health Institute News Service examines accountable care organizations (ACOs): "In an effort to combat the lack of coordination that is widely recognized as a major shortcoming of the current health system, the new federal health reform law includes provisions intended to encourage wider use of Accountable Care Organizations or ACOs."
The U.S. Food and Drug Administration has approved Eli Lilly's Cymbalta, a balanced and potent serotonin and norepinephrine reuptake inhibitor. Cymbalta is the first and only FDA-approved treatment for pain caused by diabetic peripheral neuropathy.
Protalix Biotherapeutics, Inc. (NYSE-Amex: PLX), announced the completion of its pivotal Phase III trial for prGCD, the Company's proprietary plant-cell expressed recombinant form of glucocerebrosidase (GCD) for the treatment of Gaucher disease. The trial enrolled a total of 31 patients across Europe, North America, South America, Israel and South Africa. No serious adverse events were reported in this trial.
A new opinion piece in The BMJ published in March 2020 discusses whether healthcare professionals should wear beards because of the risk that they could harbor the novel coronavirus.
Sundia MediTech Company, a leading pharmaceutical R&D outsourcing service company in China, is proud to announce that the company received the Red Herring Asia Top 100 Enterprises 2009 award, an award given to the top 100 private technology companies in the Asia Pacific region.
› Verified 1 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Brooke Kristine Nunemaker, OTR/L 15242 94th Pl N, Maple Grove, MN 55369-4436 Ph: () - | Brooke Kristine Nunemaker, OTR/L 15301 Grove Cir N, Maple Grove, MN 55369-4475 Ph: (952) 993-5900 |
News Archive
Kansas Health Institute News Service examines accountable care organizations (ACOs): "In an effort to combat the lack of coordination that is widely recognized as a major shortcoming of the current health system, the new federal health reform law includes provisions intended to encourage wider use of Accountable Care Organizations or ACOs."
The U.S. Food and Drug Administration has approved Eli Lilly's Cymbalta, a balanced and potent serotonin and norepinephrine reuptake inhibitor. Cymbalta is the first and only FDA-approved treatment for pain caused by diabetic peripheral neuropathy.
Protalix Biotherapeutics, Inc. (NYSE-Amex: PLX), announced the completion of its pivotal Phase III trial for prGCD, the Company's proprietary plant-cell expressed recombinant form of glucocerebrosidase (GCD) for the treatment of Gaucher disease. The trial enrolled a total of 31 patients across Europe, North America, South America, Israel and South Africa. No serious adverse events were reported in this trial.
A new opinion piece in The BMJ published in March 2020 discusses whether healthcare professionals should wear beards because of the risk that they could harbor the novel coronavirus.
Sundia MediTech Company, a leading pharmaceutical R&D outsourcing service company in China, is proud to announce that the company received the Red Herring Asia Top 100 Enterprises 2009 award, an award given to the top 100 private technology companies in the Asia Pacific region.
› Verified 1 days ago
Ms. Renee Haroldson, OTRL CHT Occupational Therapist Medicare: Accepting Medicare Assignments Practice Location: 14500 99th Ave N, #1-210, Maple Grove, MN 55369 Phone: 763-898-1778 Fax: 763-898-1771 | |
Jennifer Alders, Occupational Therapist Medicare: Medicare Enrolled Practice Location: 6936 Garland Ln N, Maple Grove, MN 55311 Phone: 763-416-9313 Fax: 763-416-4530 | |
Mark A Narveson, O.T. Occupational Therapist Medicare: Accepting Medicare Assignments Practice Location: 7767 Elm Creek Blvd N Ste 160, Maple Grove, MN 55369 Phone: 763-201-8191 | |
Heather Renee Elder, OTR/L Occupational Therapist Medicare: Accepting Medicare Assignments Practice Location: 7767 Elm Creek Blvd N Ste 160, Maple Grove, MN 55369 Phone: 763-201-8191 Fax: 763-201-8192 | |
Mrs. Cheryl Anne Salim, OTR/L Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 16500 92nd Ave N, Maple Grove, MN 55311 Phone: 763-493-5910 | |
Megan Kay Holmgren, OTR/L Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 6936 Garland Ln N, Maple Grove, MN 55311 Phone: 763-416-9313 | |
Inga Rohde, Occupational Therapist Medicare: Medicare Enrolled Practice Location: 11100 86th Ave N, Maple Grove, MN 55369 Phone: 763-755-4275 |